ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Religare Enterprises Limited held its 42nd Annual General Meeting on September 24, 2026, where members adopted financial statements and approved the re-designation of Mr. Arjun Lamba.
Religare Enterprises' subsidiary, Care Health Insurance Limited, has allotted non-convertible debentures aggregating to ₹100 Crore. These securities will be listed on the NSE.
Religare Enterprises Limited has approved the continuation of Mr. Rajender Mohan Malla as the Non-Executive Chairperson for the quarter ending December 31, 2026.
Religare Enterprises informed that the Securities Appellate Tribunal dismissed its appeal against an earlier SEBI order. The company is sharing this legal update for record.
India Ratings affirmed the existing credit rating and assigned a new subordinated debt rating of IND AA-/Stable to Care Health Insurance, a material subsidiary of Religare.
Religare Enterprises Limited has scheduled its 42nd Annual General Meeting for September 24, 2026, to be held via Video Conferencing.
Ashish Dhawan acquired 38,00,000 equity shares of Religare Enterprises Limited via an open market purchase. This transaction increases his shareholding in the company.
Religare Enterprises Limited acquired equity shares of its wholly-owned subsidiary, Religare Broking Limited, through a rights issue for ₹100.00 Crore.
Religare Q1FY27 shows strategic focus on core segments. Consolidated revenue grew 26% YoY to ₹2,358 Cr, though PAT remains negative at ₹46.9 Cr due to reporting standard transitions and investment modes.
Religare Enterprises Limited announced a change in designation for Mr. Arjun Lamba. He has transitioned from Wholetime Director to Executive Director.
Religare reported Q1 FY27 consolidated revenue of Rs. 2,358.4 Cr, up 26% YoY, driven by strong performance in the Insurance segment. Net profit turned into a loss of Rs. 46.9 Cr.
Religare Enterprises Ltd reported revenue from operations of ₹2.5 Cr (+1150.0% YoY) and a net loss of ₹9.6 Cr for Q1 FY27.
Religare Enterprises Ltd reported revenue from operations of ₹2,353 Cr (+25.7% YoY) and a net loss of ₹47 Cr for Q1 FY27.
Religare Enterprises Limited has amended its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information, in compliance with SEBI Regulations.
Religare Enterprises has granted 13,195 stock options under its ESOP Scheme 2019. The options vest in five equal annual instalments of 20% each.